Rezultaty - Paramesh Shamanna

  • Rezultaty 1 - 5 Rezultaty od 5
Redukuj rezultaty
  1. 1
    Digital Twin-Enabled Personalized Nutrition Improves Metabolic Dysfunction-Associated Fatty Liver Disease in Type 2 Diabetes: Results of a 1-Year Randomized Controlled Study

    Digital Twin-Enabled Personalized Nutrition Improves Metabolic Dysfunction-Associated Fatty Liver Disease in Type 2 Diabetes: Results of a 1-Year Randomized Controlled Study od Shashank Joshi, Paramesh Shamanna, Mala Dharmalingam, Arun Vadavi, Ashok Keshavamurthy, Lisa Shah, Jeffrey I. Mechanick

    Wydane 2023
    Dokumenty pełnotekstowe Dokumenty pełnotekstowe
    Artigo
    Dodaj do listy ulubionych książek
    Zapisane w:
  2. 2
    Reducing HbA1c in Type 2 Diabetes Using Digital Twin Technology-Enabled Precision Nutrition: A Retrospective Analysis

    Reducing HbA1c in Type 2 Diabetes Using Digital Twin Technology-Enabled Precision Nutrition: A Retrospective Analysis od Paramesh Shamanna, Banshi Saboo, Suresh Damodharan, Jahangir Mohammed, Maluk Mohamed, Terrence Poon, Nathan L. Kleinman, Mohamed Thajudeen

    Wydane 2020
    Dokumenty pełnotekstowe Dokumenty pełnotekstowe
    Artigo
    Dodaj do listy ulubionych książek
    Zapisane w:
  3. 3
    Retrospective study of glycemic variability, BMI, and blood pressure in diabetes patients in the Digital Twin Precision Treatment Program

    Retrospective study of glycemic variability, BMI, and blood pressure in diabetes patients in the Digital Twin Precision Treatment Program od Paramesh Shamanna, Mala Dharmalingam, Rakesh Sahay, Jahangir Mohammed, Maluk Mohamed, Terrence Poon, Nathan L. Kleinman, Mohamed Thajudeen

    Wydane 2021
    Dokumenty pełnotekstowe Dokumenty pełnotekstowe
    Artigo
    Dodaj do listy ulubionych książek
    Zapisane w:
  4. 4
    Beneficial effects of once-daily lixisenatide on overall and postprandial glycemic levels without significant excess of hypoglycemia in Type 2 diabetes inadequately controlled on a sulfonylurea with or without metformin (GetGoal-S)

    Beneficial effects of once-daily lixisenatide on overall and postprandial glycemic levels without significant excess of hypoglycemia in Type 2 diabetes inadequately controlled on a... od Julio Rosenstock, M Hanefeld, Paramesh Shamanna, Kyung Wan Min, Gabor Boka, P. Miossec, Tianyue Zhou, Isabel Muehlen-Bartmer, Robert E. Ratner

    Wydane 2014
    Dokumenty pełnotekstowe
    Artigo
    Dodaj do listy ulubionych książek
    Zapisane w:
  5. 5
    Efficacy and Safety of Remogliflozin Etabonate, a New Sodium Glucose Co-Transporter-2 Inhibitor, in Patients with Type 2 Diabetes Mellitus: A 24-Week, Randomized, Double-Blind, Active-Controlled Trial

    Efficacy and Safety of Remogliflozin Etabonate, a New Sodium Glucose Co-Transporter-2 Inhibitor, in Patients with Type 2 Diabetes Mellitus: A 24-Week, Randomized, Double-Blind, Act... od Mala Dharmalingam, S. R. Aravind, Hemant Thacker, Paramesh Shamanna, Brij Mohan, Manoj Chawla, Arthur Asirvatham, Ramesh K. Goyal, Jayashri Shembalkar, Balamurugan Ramadass, Pradnya Kadam, Hansraj Alva, Rahul Kodgule, Monika Tandon, Sivakumar Vaidyanathan, Amol Pendse, Rajesh Gaikwad, Sagar Katare, Sachin Suryawanshi, Hanmant Barkate

    Wydane 2020
    Dokumenty pełnotekstowe Dokumenty pełnotekstowe
    Artigo
    Dodaj do listy ulubionych książek
    Zapisane w:

Narzędzie wyszukiwania: